USANA Health Sciences Insider Receives RSU Shares, No Sales Filed

Rhea-AI Filing Summary

USANA Health Sciences (USNA) – Form 4 filing: Director Gilbert A. Fuller reported the first vesting tranche of a previously granted restricted-stock-unit (RSU) award.

• Transaction date: 24 Jul 2025
• Type (Code M): automatic conversion of RSUs into common shares
• Shares acquired: 1,058 common shares at $0 cost
• Post-transaction ownership: 1,058 common shares held directly and 3,172 RSUs still outstanding
• Vesting schedule of remaining RSUs: 25 % on 23 Oct 2025, 22 Jan 2026, and 23 Apr 2026

The filing reflects routine equity-based compensation; no shares were sold and no cash proceeds were involved. The transaction is unlikely to materially affect the company’s share float or signal a directional view beyond normal incentive alignment.

Positive

• Director increased direct equity stake by 1,058 shares, modestly aligning insider incentives with shareholders.

Negative

• None.

Insights

Equity Compensation Analyst

TL;DR: Director merely received 1,058 shares from RSU vesting; no buy/sell, negligible float impact.

The Code M conversion is a non-open-market event and therefore neutral for supply/demand dynamics. Fuller still holds 3,172 unvested RSUs, indicating continued alignment with long-term performance. Absence of share disposal suggests no negative insider sentiment. For a company with ~19 M shares outstanding, 1,058 shares (≈0.006 %) have no valuation significance. Overall, the disclosure is routine and non-impactful.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

FULLER GILBERT A

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/24/2025		M		1,058	A	(1)	1,058	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/24/2025		M			1,058	(2)	(2)	Common Stock	1,058	$0	3,172	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many USNA shares did Director Gilbert A. Fuller acquire on 24 July 2025?

1,058 common shares were acquired through RSU conversion.

What does transaction code "M" mean in the USNA Form 4?

Code M indicates the exercise or conversion of derivative securities such as RSUs into common stock.

How many restricted stock units does Fuller still hold after the transaction?

He retains 3,172 unvested RSUs that will vest in three future tranches.

Were any USNA shares sold or dispositions reported in this Form 4?

No. The filing reports only an acquisition of shares; no sales were disclosed.